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Like virtually all endocytic receptors. the human asialoglycoprotein (ASGP) receptor isphosphorylated byprotein kinasc Cat serine residues within 
the cytoplasmic domains of its two subunits HI and HZ. Activation of protein kinasc C by phorbol esters results in hypcrphosphorylation a d 
in a concomitant net redistribution of receptors to intracellular compartments (down-regulation) i  HcpG2 cells. To test whether there is a causal 
relationship between receptor hyperphosphorylation a d rctiistribution, we examined the erect ofphorbol ester treatment on the ASGP receptor 
composed of either wild-type subunits or of mutant subunits lacking any cyloplssmic serinc residues in transfccted NIH3T3 Rbroblast and COS-7 
cells. Although the wild-typcsubunits were hypcrphosphorylatcd in fibroblast cells, thedistribution ofneithcr the wild-type nor the mutant receptors 
was affected. In contrast, phorbol ester treatment oftmnsfccted COS-7 cells induced own-regulation of both wild-type and mutant receptors. These 
findings indicale that redistribution of the rcccptor is indcpcndent of its cyloplasmic serines and is not caused by receptor phosphorylation. 
Asialoglycoprotein receptor: Endocytosis: Phorbol ester; Protein kinase C; Serine phosphorylntion 
1. INTRODUCTION 
Phorbol esters are tumor-promoting agents that acti- 
vate protein kinasc C. They mimick the action of the 
second messenger diacyl glycerol which, together with 
inositol phosphates, is produced from phosphoinosi- 
tides by phospholipase C upon activation by hormone 
receptors at the cell surface. Phorbol esters are thus 
useful as pharmacological gents to analyze the effects 
of the diacyl glycerol branch of the signal pathway. 
Activated protein kinase C associates with the plasma 
membrane and phosphorylates a variety of proteins at 
cytoplasmic serine or threonine residues. This Anally 
results in a complex and tissue-specific pattern of cellu- 
lar responses (reviewed by Nishizuka [I]). 
Among the targets of protein kinase C are virtually 
all endocytic receptors, both signal-transducing 
hormone receptors and transport receptors (reviewed 
by Backer and King [2]). Upon addition of phorbol 
esters to the cells, receptors are rapidly hyper- 
phosphorylated at specific residues within their cyto- 
plasmic portions. In some hormone receptors, this di- 
rectly affects the affinity of ligand binding (epidermal 
growth factor [EGF] receptor [3]) or modulates ignal 
transduction (insulin receptor [4]). In many receptor 
systems, hyperphosphorylation is also temporally cor- 
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related with changes in the kinetics of endocytosis and/ 
or recycling and in the cellular receptor distribution 
(e.g. receptors for transferrin, asialoglycoproteins 
[ASGP], mannose-G-phosphate [5-S]). In most cases 
surface binding sites are ‘down-regulated’ upon phorbol 
ester treatment, i.e. the surfam-to-intracellular distribu- 
tion is shifted in favor of the intracellular pool. This 
phenomenon could suggest hat receptor phosphoryla- 
tion/dephosphorylation might be necessary for endocy- 
tosis and/or recyling also in unstimulatcd cells. Alterna- 
tively, receptor phosphorylation might play a role only 
in modulating receptor traffic. 
The first suggestion has so far not been substantiated: 
site-specific mutagenesis of the phorbol ester-stimulated 
phosphorylation site in the EGF receptor (threoninc- 
654) did not hinder constitutive or ligand-induced inter- 
nalization [9]. Similarly, deletion of the carboxy-termi- 
nal portion of the insulin receptor, including the phos- 
phorylation site threonine-1336, did not affect internal- 
ization in response to insulin [IO]. Mutation of the 
unique phosphorylation site of the transferrin receptor, 
serine-24, did not alter ligand uptake and receptor cy- 
cling [11,12], nor was there any detectable functional 
difference between the wild-type ASGP receptor and a 
mutant receptor lacking all cytoplasmic serine residues, 
including its phosphorylation sites [I 31. 
However, the phorbol ester effects have been shown 
to deptind on receptor phosphorylation in at least two 
systems. It was found that phosphorylation of threon- 
ine-654 of the EGF receptor is necessary for ligand- 
independent internalization triggered by phorbol esters 
[9], Similarly, phorbol ester-induced internalization of 
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the T-cell surface antigen CD4 depends directly on the 
three serines that are phosphorylated by protein kinasc 
C [14]. In contrast, it was reported for the transferrin 
receptor that its redistribution upon phorbol ester treat- 
ment was independent of phosphorylation at serine-24 
[15,16]. 
In this study, we have analyzed the importance of 
phorbol ester-induced hyperphosphorylation for the in- 
tracellular distribution of the human ASGP receptor. 
This receptor (reviewed by Spiess 1171) isa constituent 
of the plasma membrane of hepatocytes and is responsi- 
ble for the clearance of desialylated (galactosyl-termi- 
nal) glycoproteins from the circulation. The ASGP re- 
ceptor consists of two homologous ubunits, HI and H2 
[ 181, which foml a hetero-oligomeric complex necessary 
for the formation of high-affinity ligand binding sites 
[19]. In hepatocytes and the human hcpatoma cell line 
MepG2, Hl is approximately four times as abundant as 
I-12. Mobility measurements suggest a ratio of three HI 
subunits to one H2 subunit in the native receptor com- 
plex [20]. 
The ASGP receptor is exclusively pbosphorylated at 
serine residues 1211, predominantly at serine-12 of sub- 
unit H2, and weakly also at serines 16 and 37 of subunit 
Hl, both at steady-state and upon phorbol ester treat- 
ment [ 131. However, ligand uptake and degradation was 
not affected by mutation of all five cytoplasmic serine 
residues in the ASGP receptor subunits in untreated 
cells, demonstrating that srrine phosphorylation is not 
essential for receptor cycling. Yet, addition of phorbol 
esters to HepG2 cells was shown to reduce the number 
of surface receptors by 40-508 coordinately with recep- 
tor hyperphosphorylation [7,22]. The rate of internali- 
zation remained unchanged, suggestiuy a phorbol ester 
effect on the rate of receptor recycling [23]. To test 
whether eceptor down-regulation iscaused by receptor 
phosphorylation, we have analyzed the phortol ester 
effect on wild-type and mutant receptors in transfected 
cell lines. The results indicate that receptor adistribu- 
tion is independent of cytoplasmic serine residues and 
is therefore not a consequence of receptor phosphoryla- 
tion. 
2. MATERIALS AND METHODS 
2.1. Cell crtlturc and tramJ~ctim 
Cell culture reagents were purchased from Gibco Laboratories. 
HepG2 and COS-7 cells were grown in minimal essential medium 
(MEM) with IO% felal calf serum. and NlH3T3 fibroblast cells in 
DulbLwco’s MEM containing 10% bovine calf serum (InotLvh. Swit- 
zerland). The media were supplemented with 2 mM t.-glutamine. 100 
U/ml penicillin and 100 &ml streptomycin. The cell line l-7-l was 
derived from mouse NIH3T3 fibroblasts as described by Shia and 
Lodish [l9]. The Fl-2(S5) fibroblast cell line was described previously 
[13]. For transient expression i  COS-7 cells, wild-type and mutant 
cDNAY were subcloned into the expression plasmid pECE [24] and 
transfected according to Cullcn [Xl in IO-cm dishes. To ensure uni- 
form expression within each experiment, he cells were trypsinized. 
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mixed, and seeded into 35 mm-dishes I2 h after trnnskction. The cells 
were used for experiments 24 h later (i.e., 36 h after transfection). 
2.2. Detcrrrtirrathr ofstttf~~c~ ligand hittdittg sitps 
Preparalion and iodinulion of asialoorosomucoid (ASOR) and li- 
gand binding was pcrformcd as described previously [19]. Cells were 
incubated at 4’C for 2 h with 2,@ml ‘zsI-ASGR. Non-specific binding 
was determined in the presence of200-fold excess of unlabeled ligand, 
or by selcctivcly removing the bound ligand by 3 washes with PBS, pH 
5. containing 10 mM EDTA. The effect of phorbol esters on surface 
receptors was determined after I h preincubation with 200 nM 4,k 
phorbol 12.13.dibutyrate (PdB) or with 200 nM 4a-phorbol (both 
from Sigma) at 37°C prior to ligand binding for 2 h at 4°C. 
2,3. lrrtctrtakatiorr usmy 
Cells were incubated at 4°C for2 h with lyg/ml “‘1-ASOR, washed 
3 times ‘Nitlr PBS, and incubated for various times at 37°C. Surface- 
bound ligand was removed by 3 washes with PB3, pH 5, containing 
IO mM EDTA. Internalized ligand was quantilied by SDS-gel electro- 
phoresis of the lyscd cells, autoradiography, and dcnsitomctric scan- 
ning of the “51-ASOR band. 
2.4. DcWwnhatio/~ of rrccptor distrihtiotr 
Cells were treated with or without I mgktl proteinasc K (Scrva) at 
4OC for 30 min, digestion was stopped by addition of 2 mM phen- 
ylmethylsulfonyl f uoride, and protease-resistant receptor was ana- 
lyzed by immunoblotting as previously described 1261. Alternatively, 
cell surraco receptors were quantitated using ‘?$I-labeled IgG purified 
from a rabbit antiserum directed against ASGP rcccptor subunit HI, 
Cells were incubated with saturating concentrations of1z51-1gG in PBS 
containing 1 m&/ml bovine serum albumin at 4°C for 2 h and then 
wvashcd 3 times with PBS, Cell-associated radioactivity was dcler- 
mined by gamma counting and by SDS-gel elcctropboresis of the lysed 
cells. autoradiography, and densitomctric scanning. 
3. RESULTS AND DISCUSSION 
3. I. PlrorBol ester-induced t-ccepror rediskbution is de- 
pendetrt ott the ceN rype 
To examine the effect of phorbol esters on receptor 
distribution, stable cell lines expressing wild-type or mu- 
tant ASGP receptor subunits were preincubated with 
200 nM 4,&phorbol 12,13-dibutyrate (PdB) or with the 
same concentration of the inactive compound 4cr-phor- 
bol for 1 h at 37OC. The cells were then chilled to 4OC 
and incubated with a saturating concentration of ‘?‘l- 
iodinated ASOR for 2 h to determine the number of 
ligand binding sites on the cell surface. In agreement 
with previous reports [7, 231, PdB caused a 30-40% 
reduction of surface binding sites in HepG2 cells which 
naturally express the functional ASGP receptor (Fig. 1). 
This effect is the result of net internalization of receptors 
rather than a permanent change in affinity or total num- 
ber of binding sites, since an equivalent reduction of Hl 
polypeptides on the surface was determined (Fig. 2 and 
VI). 
To compare the phorbol ester effect on wild-type and 
mutant receptors, stable transfected cell lines, which 
normally do not express the ASGP receptor, were exam- 
ined. In the mouse NIH3T3 fibroblast cell line l-7-1, 
both wild-type receptor subunits are expressed. It has 
previously been shown that they form high-affinity li- 
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Fig. I. Phorbol eskr cffec~ on surface ligand-binding sites. After pre- 
treatment or the cells for I h al 37°C with either 100 nM I’dB or the 
inactive compound 4a-phorbol, ‘!‘I-ASOR ~35 allowed to bind to the 
cell surfuce at 4°C. HcpG? cells, transfected Abroblssts (I-7-1(~) and 
FI-Z(S5)) and CO.%7 cells (COSI-2(wt) and COSI-2(55)) expressing 
G&type (wt) or mutant (S5) receptor subunits were analyzed. Ligand 
binding to PdB-treated cells is shown as a percentage ofthat ofcontrol 
cells. The average and range of two expcrimcnts. each performed in 
triplicats, is shown. 
gand binding sites and mediate @and uptake very sim- 
ilarly to the endogenous receptor in HcpG2 cells [19], 
and that they arc internalized and recycled also consti- 
tutively (Le., in the absence of ligand [26]). As in HepG2 
cells, predominantly subunit H2 was found to be 
phosphoryla.tcd in l-7-1 cells and upon PdB treatment 
phosphorylation of both subunits was enhanced sev- 
eral-fold [13]. Yet, the receptor distribution was not 
significantly affected by phorbol ester treatment: both 
the number of surface binding sites and the amount of 
H 1 protein on the cell surface remained unchanged after 
stimulation (Fig. 1 and 2). No change in receptor dis- 
trubution could be observed even at concentrations of 
up to 1 mM PdB and when another active compound, 
4b-phorbol 12-myristate 13-acetate, was used (data not 
shown). Thus, while fibroblasts and HepG2 cells re- 
spond similarly to phorbol esters with respect o recep- 
tor phosphorylation, they differ in their response with 
respect o receptor edistribution. 
Not surprisingly, a mutant ASGP receptor in which 
all cytoplasmic serines (at pcsitions 16 and 37 of Hl, 
and 12, 13, and 55 of HZ?) were exchanged by alanine 
or glycine also did not respond to PdB treatment in the 
stably expressing fibroblast cell line FI-2(S5) (Figs. 1 
and 2). 
3.2. Tmasimt expwsion of functioned receptors in 
lrrrrrsfecled COS-7 cells 
Transient expression in COS cells is a convenient 
method to rapidly produce proteins in sufficient 
amounts for structural and functional analysis. We have 
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Fig. 2. Phorbol ester effect on surface receptor protein H 1. The r&live 
amount of Ihe receptor subunit Hl was determined ai& treatment of
the indicated cells with either 200 nM PdB or the inactive compound 
4a-phorbol for I II at 37V. Surface HI was dctcrmincd either by 
protcinasc K digestion and immunoblotanslysls orresistant H1 or by 
binding of “%sdinated anti-H1 l&G to the cell surface (a~ described 
in section 2). Surface HI of PdB-treated cells is shown as percen@c 
of that of control cells. The average of duplicate or lripkxitc dctcmi- 
nations is shown. 
transfected wild-type and mutant receptor cDNAs into 
COS-7 cells using the plasmid vector pECE. Maximal 
rates of synthesis and accumulation of the receptor sub- 
units were reached 48-72 h after transfection. In this 
period, approximately 5times as many surface binding 
sites per milligram of protein could be measured as in 
HepG2 cells, while no specific binding was detectable in 
mock-transfected COS-7 cells. Moreover, during incu- 
bation at 37°C bound ligand gradually acquired resis- 
tance to low pH/EDTA stripping, demonstrating &and 
internalization, both in cells expressing wild-type or mu- 
tant receptor (not shown). However, the rates of endo- 
cytosis were very low, most likely because of substantial 
overexpression i the successfully transfected subpopu- 
lation of the cells resulting in saturation of the endocytic 
machinery. 
If the cells were analyzed at earlier times after trans- 
fection (36 h), similar numbers of surface binding sites 
per mg of protein were expressed as in HepG2 cells. In 
addition, ligand internalization was found to be more 
efficient: close to 50% of ?ASOR bound to the cells 
at 4*C acquired resistance to low pH/EDTA stripping 
within 20 min at 37OC. As in the fibroblast cell lines 
1-7-1 and Fl-2(S5) [13], ligand binding and uptake in 
transfected COS-7 cells does not depend on serine phos- 
phorylation of the receptor subunits: wild-type and mu- 
tant subunits lacking all cytoplasmic serines yielded 
equally functional receptor complexes. 
3.3, Phorbol ester effects on trutrsfected COS-7 cells 
The functional expression of ASGP receptors in 
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transfectcd COS-7 cells made it possible to examine the 
effect of phorbol esters on the distribution of either the 
wild-type receptor or the mutant lacking cytoplasmic 
serines in this cell type. Both ligand binding sites and 
receptor protein were found to be reduced on the cell 
surface upon PdB treatment by 30-40% in comparison 
to control cells (Figs. 1 and 2). Thus, COS cells do 
respond to PdB treatment by down-regulation of the 
ASGP receptor, similar to HepG2 cells but unlike fi- 
broblasts. Importantly, redistribution occurred equally 
for the wild-type and the mutant receptor subunits. This 
result strongly argues against a causal relationship be- 
tween serine phosphorylation of the receptor and its 
phorbol ester-induced redistribution. 
The ASGP receptor thus appears to behave similarly 
to the transferrin receptor. The only phosphorylated 
residue of the transferrin receptor, serine-24, isnot nec- 
essary for receptor cycling [11,12]. and mutation of this 
residue to threonine or alanine did not affect the phor- 
bol ester-induced receptor redistribution in Swiss 3T3 
and CHO cells [ 15,161, In these two cell lines, phorbol 
esters induce an increase in surface transferrin recep- 
tors. This is in contrast to K562 and HL60 leukemic 
cells in which the number of surface receptors are re- 
duced due to a phorbol ester-induced increase in the 
rate of internalization [5,6,27,28]. It has been suggested 
r’nar the two processes may involve different cellular 
mechanisms 121; the dependence of transferrin receptor 
down-regulation on its phosphorylation has not been 
demonstrated directly. 
Our study on the ASGP receptor in transfected COS- 
7 cells shows that PdB-induced own-regulation isinde- 
pendent of receptor phosphorylation and of cytoplas- 
mic serine residues. Receptor edistribution is therefore 
more likely an indirect effect of protein kinase C activa- 
tion acting more generally on membrane traffic, as has 
previously been suggested by Buys et al. [29] in studies 
on the phorbol ester effects on macrophages. Since in 
addition, serine phosphorylation of the ASGP receptor 
is not necessary for endocytosis and recycling [13], and 
mutation of the cytoplasmic serines of subunit HI does 
not affect its correct transport o the basolateral surface 
in transfected Madin-Darby canine kidney cells (B. Le- 
itinger, 1. Geffen, and M. Spiess, unpublished results), 
no functional role is known for this modification in the 
ASGP receptor. 
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